drugset / Trial / NCT03062059
The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence
Phase 2
Unknown
134 enrolled
National Cancer Center, Korea
Asan Medical Center · collabChong Kun Dang Pharmaceutical · collabKorea University Anam Hospital · collabSamsung Medical Center · collabSeoul National University Hospital · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
The aim of this study is to evaluate the effectiveness and safety of intravesical gemcitabine instillation during operation to prevent intravesical recurrence after radical nephroureterectomy in upper urinary tract urothelial carcinoma.
Timeline
- Start
- 2018-03-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 52.6 ml | Other |
| Subject | Gemcitabine | Small molecule | 2000 mg | Other |